论文部分内容阅读
目的:分析厄贝沙坦治疗原发性高血压的用药效果与优越性。方法:抽取我院2015年1月~2016年10月我院收治的82例高血压患者作为研究对象,根据随机数字法,将82例患者分成两组,其中一组41例患者给予依那普利治疗设为对照组,另外一组取其余41例患者给予厄贝沙坦治疗设为观察组,比较两组治疗效果,血压变化情况及不良反应情况。结果:观察组总有效率92.68%与对照组总有效率58.54%对比,观察组有效率更高,两组对比有显著差异(P<0.05);观察组收缩压、舒张压水平与对照组相比,改善效果更为理想,两组对比有显著差异(P<0.05);观察组不良反应发生率2.44%与对照组不良反应发生率14.63%对比,观察组不良反应更低,两组对比有显著差异(P<0.05)。结论:原发性高血压患者应用厄贝沙坦治疗疗效确切,改善患者收缩压、舒张压水平较好,而且对患者产生的不良反应较少,值得推广应用。
Objective: To analyze the efficacy and superiority of irbesartan in the treatment of essential hypertension. Methods: Totally 82 hypertensive patients admitted to our hospital from January 2015 to October 2016 were selected as subjects. According to the random number method, 82 patients were divided into two groups. One group of 41 patients were given enalapril Lee treatment as the control group, the other group taking the remaining 41 patients given irbesartan treatment as the observation group, the treatment effect, blood pressure changes and adverse reactions were compared. Results: The total effective rate in the observation group was 92.68% compared with the total effective rate in the control group (58.54%), and the observation group was more effective, with significant difference between the two groups (P <0.05). The systolic and diastolic blood pressure (P <0.05). The incidence of adverse reactions in the observation group was 2.44%, which was significantly lower than that in the control group (14.63%). The adverse reactions in the observation group were lower than those in the control group Significant difference (P <0.05). Conclusion: The treatment of irbesartan in patients with essential hypertension is effective and the systolic blood pressure and diastolic blood pressure of patients with hypertension are better, and the patients have fewer adverse reactions, which is worth popularizing and applying.